Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription 18.05.2026 2 Am J Ophthalmol 1 Ann Surg Oncol 2 Br J Dermatol 2 J Invest Dermatol 4 Melanoma Res 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Ophthalmol

1. DAVE N, Taylor Gonzalez DJ, Cernichiaro-Espinosa LA, King BA, et al
   One-Year Tumor Volume Regression Predicts Survival After I-125 Plaque Brachytherapy for Posterior Uveal Melanoma.
   Am J Ophthalmol. 2026 May 12:S0002-9394(26)00239.
   PubMed         Abstract available
   
   
2. VAISMAN D, Pe'er J, Eiger-Moscovich M, Lotem M, et al
   Reply to comments on Interferon Alpha-2a as Treatment for Primary Acquired Melanosis with Atypia (PAMwA) and for PAMwA surrounding conjunctival melanoma.
   Am J Ophthalmol. 2026 May 9:S0002-9394(26)00226.
   PubMed        
   
   

   
   Ann Surg Oncol

3. BARTLETT EK, Panageas KS, Coit DG
   Perspective Editorial: Assessment of Survival Benefit from Sentinel Node Biopsy for Melanoma: A Systematic Review and Meta-analysis.
   Ann Surg Oncol. 2026 May 8. doi: 10.1245/s10434-026-19776.
   PubMed        
   
   

   
   Br J Dermatol

4. MCGRATH JA, Olsen CM
   Mole counts, melanoma, and the dermatologist's next "vital sign".
   Br J Dermatol. 2026 May 9:ljag178. doi: 10.1093.
   PubMed        
   
   
5. KARPONIS D, Nikolaou V, Stratigos AJ, Mistry K, et al
   Epidemiology of lentigo maligna and lentigo maligna melanoma in England between 2013-2023.
   Br J Dermatol. 2026 May 8:ljag177. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Invest Dermatol

6. SAHU A, Gill M, Hermawan A, Shinde A, et al
   PARP1 as a biomarker for differentiating melanoma from benign melanocytic lesions.
   J Invest Dermatol. 2026 May 12:S0022-202X(26)01198.
   PubMed        
   
   
7. JAYASINGHE D, Torrano J, Betz-Stablein B, Janda M, et al
   Nevus clustering on the back associated with in situ melanoma in a Queensland melanoma high-risk cohort.
   J Invest Dermatol. 2026 May 6:S0022-202X(26)01186.
   PubMed        
   
   

   
   Melanoma Res

8. AZIZ H, Pirzada H, Ahmad A, Iqbal J, et al
   Re-evaluating melanoma treatment: a comparative look at herpes simplex virus and coxsackievirus oncolytic therapies in advanced melanoma: a meta-analysis of clinical trials.
   Melanoma Res. 2026 May 14. doi: 10.1097/CMR.0000000000001105.
   PubMed         Abstract available
   
   
9. VAN DOREN AGS, Shah H, Chen R, Shah D, et al
   Variability in synoptic reporting and inclusion of essential histopathologic elements in cutaneous melanoma biopsy pathology reports.
   Melanoma Res. 2026 May 14. doi: 10.1097/CMR.0000000000001106.
   PubMed         Abstract available
   
   
10. ZHANG Y, Borna S, Saw-Martinez R
    Sentinel lymph node detection in melanoma: indocyanine green fluorescence compared with conventional mapping techniques.
    Melanoma Res. 2026 May 11. doi: 10.1097/CMR.0000000000001104.
    PubMed         Abstract available
    
    
11. DALVIN LA, Burr SD, Miley DR, Ong H, et al
    Novel uveal melanoma patient-derived cell line and organoid models show increased treatment resistance compared with commercially available cell lines.
    Melanoma Res. 2026 May 11. doi: 10.1097/CMR.0000000000001103.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

12. YANG X, Qiao X, Schmidt S, Eklund EA, et al
    ICMT supports BRAF(V600E)-driven tumor growth by membrane targeting of the CAAX protein INPP5E.
    Proc Natl Acad Sci U S A. 2026;123:e2601795123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum